EA202092110A1 - AMINO ACID COMPOUNDS AND METHODS OF APPLICATION - Google Patents

AMINO ACID COMPOUNDS AND METHODS OF APPLICATION

Info

Publication number
EA202092110A1
EA202092110A1 EA202092110A EA202092110A EA202092110A1 EA 202092110 A1 EA202092110 A1 EA 202092110A1 EA 202092110 A EA202092110 A EA 202092110A EA 202092110 A EA202092110 A EA 202092110A EA 202092110 A1 EA202092110 A1 EA 202092110A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
application
amino acid
acid compounds
formula
Prior art date
Application number
EA202092110A
Other languages
Russian (ru)
Inventor
Якоб Ча
Чэнго Дун
Тимоти Хом
Лань Цзян
Катерина Лефтерис
Хой Ли
мл. Дэвид Дж. Морганс
Мануэль Муньос
Морин Рейлли
Яцзюнь Чжэн
Original Assignee
Плайэнт Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плайэнт Терапьютикс, Инк. filed Critical Плайэнт Терапьютикс, Инк.
Priority claimed from PCT/US2019/021243 external-priority patent/WO2019173653A1/en
Publication of EA202092110A1 publication Critical patent/EA202092110A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Данное изобретение относится к соединениям формулы (А) и формулы (I)или к их солям, где R1, R2, R10, R11, R12, R13, R14, R15, R16, q и р являются такими, как описано в данном документе. Соединения формулы (A), формулы (I) и их фармацевтические композиции являются ингибиторами интегрина v6, которые пригодны для лечения фиброза, такого как идиопатический фиброз легких (IPF) и неспецифическая интерстициальная пневмония (NSIP).This invention relates to compounds of formula (A) and formula (I) or salts thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. The compounds of formula (A), formula (I) and pharmaceutical compositions thereof are inhibitors of v6 integrin which are useful in the treatment of fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).

EA202092110A 2018-06-27 2019-03-07 AMINO ACID COMPOUNDS AND METHODS OF APPLICATION EA202092110A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862690933P 2018-06-27 2018-06-27
PCT/US2019/021243 WO2019173653A1 (en) 2018-03-07 2019-03-07 Amino acid compounds and methods of use

Publications (1)

Publication Number Publication Date
EA202092110A1 true EA202092110A1 (en) 2021-02-15

Family

ID=74855473

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202092110A EA202092110A1 (en) 2018-06-27 2019-03-07 AMINO ACID COMPOUNDS AND METHODS OF APPLICATION

Country Status (1)

Country Link
EA (1) EA202092110A1 (en)

Similar Documents

Publication Publication Date Title
PH12020551395A1 (en) Amino acid compounds and methods of use
EA202190967A1 (en) AMINO ACID COMPOUNDS AND METHODS OF APPLICATION
CR20210041A (en) Amino acid compounds with unbranched linkers and methods of use
EA201892007A1 (en) 3-DESOXY DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ON ITS BASIS
EA201890899A1 (en) PHARNESIDE X-RECEPTOR MODULATORS
EA201390877A1 (en) SUBSTITUTED 6,6-CONDENSED NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION
EA201492285A1 (en) COMPOUNDS OF N-ALKYLTRIAZOLE AS ANTAGONISTS OF LYSOPHOSPHATID ACID (LPAR)
PE20070593A1 (en) PYRROLOPYRIMIDINE COMPOUNDS AS SYK INHIBITORS
EA201071329A1 (en) ADAMANTANIA DIAMID DERIVATIVES AND THEIR APPLICATION
EA202090119A1 (en) AMORPHIC AND CRYSTALLINE FORMS OF IDO INHIBITORS
EA202190275A1 (en) SUCCINATE AND FUMARATE ACID-ADDITIVE SALTS OF PIPERAZINE DERIVATIVES SUITABLE AS GLYCOSIDASE INHIBITORS
EA201101301A1 (en) SODIUM SALT 5-CYCLOPROPYL-2 - {[2- (2,6-DIFTORPHENYL) PYRIMIDIN-5-IL] AMINO} BENZOIC ACID AS DHODH INHIBITORS
EA201891506A1 (en) INDINLINE CONNECTIONS AND THEIR APPLICATION IN THE TREATMENT OF FIBROUS DISEASES
EA201691962A1 (en) AMIDOSED NITROGEN COMPOUNDS AS TNKS1 AND / OR TNKS2 INHIBITORS
CL2020001420A1 (en) Procedure for the preparation of (3s) -3- (4-chloro-3 - {[(2s, 3r) -2- (4-chlorophenyl) -4,4,4-trifluoro-3-methylbutanoyl] amino} phenyl) -3-cyclopropylpropanoic acid and its crystalline form for use as an active pharmaceutical ingredient.
EA201590669A1 (en) DERIVATIVES OF N- (2- (CYCLIC AMIN) ETHYL) BENZAMIDE AS P2X7 INHIBITORS
EA201892020A1 (en) INDOL DERIVATIVES AND THEIR APPLICATION AS PROTECTINKINASE INHIBITORS
EA201000340A1 (en) AMINOBENZYL SUBSTITUTED CYCLIC SULPHONES USEFUL AS VSE INHIBITORS
EA202092110A1 (en) AMINO ACID COMPOUNDS AND METHODS OF APPLICATION
CO2023016295A2 (en) Expanded Dosing Regimens for Integrin Inhibitors
EA201991095A1 (en) SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
EA201992877A1 (en) SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
EA201100142A1 (en) CYCLIC SULFONS, SUBSTITUTED BY AMINOBENZYL, APPLICABLE AS WSE INHIBITORS
MX2018001548A (en) A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine.